Sea Moss Tonic Recall Issued by LIQUID BLENZ CORP
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
LIQUID BLENZ CORP is voluntarily recalling Sea Moss Tonic 16 oz and 32 oz due to potential under-processing that may allow growth of Clostridium botulinum.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 11, 2026 and geographically references NY and online sales. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Food.
What Happened
LIQUID BLENZ CORP has initiated a voluntary recall of Sea Moss Tonic because the product may be under-processed resulting in growth of Clostridium botulinum and lists health claims.
Which Products Are Affected
Sea Moss Tonic 16 oz (UPC: 196852654833) and 32 oz (UPC: 196852456406). A total of 18,190 bottles are affected. Distribution was limited to NY and online sales.
What You Should Do
Consumers should not consume the recalled products and should contact LIQUID BLENZ CORP for return or refund instructions.
Why This Matters
The recall addresses a potential risk of Clostridium botulinum growth in the affected products distributed in NY and online.
Source
FDA recall number H-0784-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (724 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 11, 2026.
Frequently Asked Questions
Common questions about this FDA recall.